UPDATE 3-AstraZeneca flags falling profit while awaits key drug data

* All eyes on mid-year results from lung cancer trial (Adds further comment from CEO and CFO) [Source]

Publication Date: Thursday, 2 February 2017 at 13:10:23

Origin: reuters.com

Category: rbssHealthcareNews

Topics: comment, further, (Adds, trial, cancer, results, mid-year, awaits, while, profit, falling, flags, 3-AstraZeneca, UPDATE

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/POZl2ctwdF8/astrazeneca-results-idUSL5N1FN1GV

Related Articles

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22